Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Trees may hold the key to new discoveries about cancer and tumor formation. Fast-growing poplar trees were originally examined for potential applications in renewable energy, but were accidentally…
A research team at University of Massachusetts is investigating a recently identified type of body fat that may have beneficial effects in the body. Known as “beige fat,”…
New data shows that cabozantinib, a drug already approved in the treatment of clear cell renal cell carcinoma (ccRCC), elicited promising results in patients with less common non-clear…
Scientists at the Institute of Neuroscience, Chinese Academy of Sciences in Shanghai recently created five clones from a single gene-edited macaque monkey. The project represents a significant departure…
Urine can provide important insights into health and overall bodily function. This makes urine-testing a powerful tool in the quest to detect and treat disease. Valued for its…
David F. McDermott, MD, director of the Biologic Therapy Program at Beth Israel Deaconess Medical Center in Boston, Massachusetts presented results from the KEYNOTE-427 study at the Genitourinary Cancers…
A phase 1b study showed pembrolizumab and axitinib extended both overall survival (OS) and progression-free survival (PFS) in patients with previously untreated mRCC. “The risk of death was…
A new palm-sized device set for release in Europe can detect common pathogens in minutes. The Polish researchers who created the device, known as the SensDx, believe it…
Genetically modified chickens can lay eggs that contain an important immune-boosting human protein. Researchers at Scotland’s University of Edinburgh Roslin Institute have developed a more efficient means of…
A Massachusetts company is developing an all-in-one device that can test for many known pathogens on-site, addressing the time and cost disadvantages of having to transport samples to…
